Key Benefits
- Understand your cholesterol balance and artery-clogging particle load to gauge risk.
- Spot high ApoB or LDL-P that flags higher heart attack and stroke risk.
- Reveal hidden risk when LDL looks normal by uncovering small, dense LDL or excess particles.
- Flag high triglycerides that signal insulin resistance and raise pancreatitis risk.
- Clarify HDL quality with HDL-P and size to avoid false reassurance from HDL-C.
- Guide and track therapy using ApoB or LDL-P targets over time.
- Protect fertility and pregnancy by spotting lipid patterns linked to complications.
- Prioritize ApoB or LDL-P over particle size when making treatment decisions.
What are Dyslipidemia biomarkers?
Dyslipidemia biomarkers are the measurable fats and the proteins that carry them in blood, revealing how your body transports and disposes of lipids every day. Core measures capture the main cargo (cholesterol and triglycerides) and the vehicles that move it—low-density, high-density, and very-low-density lipoproteins (LDL, HDL, VLDL). The liver builds and recycles most of these particles, while the intestine contributes after meals (chylomicrons). As VLDL sheds triglyceride, it becomes LDL, a particle that can enter artery walls; HDL helps ferry cholesterol back to the liver (reverse cholesterol transport). Protein “tags” on particles add precision: apolipoprotein B reflects the number of artery-entering particles (apoB-containing lipoproteins), apolipoprotein A-I reflects major HDL scaffolding (apoA-I), and a genetically influenced variant, lipoprotein(a), adds a pro-atherogenic component (Lp(a)). Together, these tests map the balance between lipid delivery, storage, and clearance. They enable clinicians to identify harmful traffic patterns in the bloodstream, personalize nutrition and medication choices, and track whether the body’s lipid flow is moving toward arterial safety.
Why is blood testing for Dyslipidemia important?
Dyslipidemia testing reveals how your body packages and traffics fats through the bloodstream—information that touches the heart and vessels, liver fat handling, pancreatic safety, hormone building blocks, and even inflammation. It is less about one number and more about the number and nature of lipoprotein particles that contact artery walls.Common cut points help frame risk. LDL is best kept toward the lower end (often desirable below 100), while HDL is more protective at the higher end (≥60; low is <40 in men and <50 in women). Triglycerides are safest toward the lower end (normal <150). ApoB, a direct count of atherogenic particles, is ideally low (often <90). LDL-P, another particle count, is optimal toward the lower end (commonly <1000). HDL-P reflects the quantity of HDL particles; higher tends to be favorable. LDL size is categorized as larger (pattern A) versus smaller (pattern B), with larger being better. HDL size generally tracks benefit in the mid-to-larger range.When values are low, the meaning differs by marker. Low LDL, ApoB, and LDL-P indicate fewer artery-penetrating particles; if extremely low, they may reflect hyperthyroidism, malabsorption, or rare genetic variants, sometimes with fatigue or fat-soluble vitamin issues. Very low triglycerides can be normal or reflect hyperthyroidism or undernutrition. Low HDL and HDL-P suggest impaired reverse cholesterol transport, often seen with insulin resistance. In pregnancy, lipids rise physiologically; in children and teens, low HDL and high triglycerides often signal early metabolic risk.Big picture: these markers map energy transport and vascular exposure. They integrate with glucose metabolism, thyroid and liver function, inflammation, and genetics—helping forecast atherosclerosis, pancreatitis risk (when triglycerides are very high), and long-term cardiovascular outcomes.
What insights will I get?
Dyslipidemia blood testing provides a window into how your body manages fats, which are essential for energy, hormone production, cell structure, and brain function. Imbalances in blood lipids can disrupt cardiovascular health, metabolism, and even immune and reproductive systems. At Superpower, we measure LDL, HDL, Triglycerides, ApoB, LDL-P, HDL-P, LDL Size, and HDL Size to give a comprehensive view of your lipid profile.LDL (low-density lipoprotein) is often called “bad cholesterol” because high levels can deposit cholesterol in artery walls, increasing cardiovascular risk. HDL (high-density lipoprotein), or “good cholesterol,” helps remove cholesterol from the bloodstream. Triglycerides are the main form of fat in the blood, reflecting how your body stores and uses energy. ApoB is a protein found on LDL and other atherogenic particles, serving as a direct count of particles that can contribute to plaque buildup. LDL-P and HDL-P measure the number of LDL and HDL particles, while LDL Size and HDL Size describe the average size of these particles, which can influence their behavior in the body.A stable and healthy lipid profile—characterized by optimal levels and particle sizes—supports resilient blood vessels, efficient energy use, and balanced hormone production. Dyslipidemia, or abnormal lipid levels, can signal increased risk for atherosclerosis, metabolic syndrome, and other systemic imbalances.Interpretation of these biomarkers can be influenced by factors such as age, sex, pregnancy, acute illness, certain medications, and laboratory methods. These variables are important to consider when assessing lipid health.





.avif)










.avif)






.avif)
.avif)



.avif)

.png)